Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The United Laboratories International Holdings ( (HK:3933) ) has issued an announcement.
The United Laboratories International Holdings Limited announced the approval of a final dividend of RMB28 cents per share and a special dividend of RMB12 cents per share for the year ending December 31, 2024. These dividends will be converted to Hong Kong dollars and are expected to be paid on July 23, 2025, to shareholders listed on the register as of July 11, 2025. This announcement reflects the company’s commitment to rewarding its shareholders and could positively impact its market positioning by enhancing shareholder value.
The most recent analyst rating on (HK:3933) stock is a Hold with a HK$15.29 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, primarily engaged in the pharmaceutical industry. It focuses on the development, production, and sale of pharmaceutical products, serving a broad market with its offerings.
Average Trading Volume: 13,527,164
Technical Sentiment Signal: Buy
Current Market Cap: HK$27.26B
For detailed information about 3933 stock, go to TipRanks’ Stock Analysis page.